OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based ...

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of a new Pharmacogenomics (PGx) Beta Program to advance personalised medicine, combining ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from ...

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...

Good morning, and welcome to our 2024 Half Year Interim Results Presentation. I'm Gordon Sanghera, Chief Executive of Oxford Nanopore, and I'm joined today by our CFO, Nick Keher. Today, we will talk ...

Since the announcement, Bio-Techne’s shares have dipped 0.9%, closing at $61.19 in yesterday’s session. Asuragen brand is well known for its designed, high-quality molecular diagnostic products. The ...

RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT ® Direct RNA‑Seq (uMRT DRS) Kit, a ...

Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. It also develops instruments like GridIONTM and MinIONTM which are adaptable ...